Prajwal Paudel

Prajwal Paudel, PhD, is a seasoned biochemist currently serving as a Senior Biochemist and Tech Lead at Siemens Healthineers since September 2021, where contributions include leading assay verification for therapeutic drugs on the Atellica CI Chemistry analyzer and authoring technical design verification reports for regulatory approval. Previous experience includes roles as a Product Development Scientist at ACROBiosystems, focusing on therapeutic antibodies, and Program Lead at Apaxon Biotech LLC, where platform development for diagnostic antibodies targeting neurodegenerative diseases was emphasized. Prajwal Paudel has a strong foundation in research from the University of Delaware, where significant work involved the characterization of deubiquitinase USP9X, alongside positions as a teaching assistant and involvement in the NSF I-Corps program. Educational qualifications encompass a PhD in Biochemistry/Chemical Biology and multiple degrees in related fields from notable institutions.